Neuraxis
NRXS • AMEX
Neuraxis is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Brian Carrico, with a market cap of $77.2M.
Market Cap$77.2M
Employees19.0
CEOBrian Carrico
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Neuraxis FAQ
Common questions about Neuraxis
Neuraxis is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $1.4M.
Neuraxis has approximately 19 employees.